LON:LLAI

LungLife AI (LLAI) Share Price, News & Analysis

GBX 26
-0.50 (-1.89%)
(As of 05/3/2024 ET)
Today's Range
25
26.70
50-Day Range
26
42
52-Week Range
19
142.10
Volume
122,013 shs
Average Volume
25,344 shs
Market Capitalization
£7.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About LungLife AI

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

LLAI Stock Price History

LLAI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive LLAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LungLife AI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
£-5,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£98,566.00
Cash Flow
GBX 11.41 per share
Book Value
GBX 31 per share

Miscellaneous

Free Float
N/A
Market Cap
£7.97 million
Optionable
Not Optionable
Beta
-0.20
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Paul Pagano Ph.D. (Age 40)
    CEO, Chief Scientific Officer & Executive Director
    Comp: $269.17k
  • Mr. David M. Anderson (Age 61)
    CFO, Company Secretary & Executive Director
    Comp: $196.1k

LLAI Stock Analysis - Frequently Asked Questions

How have LLAI shares performed in 2024?

LungLife AI's stock was trading at GBX 46 on January 1st, 2024. Since then, LLAI shares have decreased by 43.5% and is now trading at GBX 26.
View the best growth stocks for 2024 here
.

How do I buy shares of LungLife AI?

Shares of LLAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:LLAI) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners